Applied Spectral Imaging

Last updated
Applied Spectral Imaging
IndustryBiomedical digital diagnostics
Founded1993;30 years ago (1993)
Headquarters,
Area served
World-wide
Key people
Limor Shiposh (CEO)
ProductsHiPath Pro
PathFusion
HiBand
HiFISH
CytoPower
Rainbow
Website spectral-imaging.com

Applied Spectral Imaging or ASI is a multinational biomedical company that develops and manufactures microscopy imaging and digital analysis tools for hospitals, service laboratories and research centers. The company provides cytogenetic, pathology, and research laboratories with bright-field, fluorescence and spectral imaging in clinical applications. Test slides can be scanned, captured, archived, reviewed on the screen, analyzed with computer-assisted algorithms, and reported. ASI system platforms automate the workflow process to reduce human error in the identification and classification of chromosomal disorders, genome instability, various oncological malignancies, among other diseases. [1] [2] [3] [4] [5]

Contents

History

Founded in 1993, ASI initially focused on spectral imaging devices for the research community. [6]

In 2002, ASI made a strategic move to expand into the clinical cytogenetics market and thereby, introduced its CytoLabView system for karyotyping and FISH imaging. [6]

In 2005, ASI launched its automated scanning system in order to increase throughput for case analysis, compensating for higher sample volumes and helping laboratories to better cope with a deficit of laboratory technicians and other professions. As the demand increased for more diagnostics, ASI focused on providing faster imaging and analysis to improve turn-around-time for patient results. Scanning automation and algorithms enabled laboratory technologists to spend more time on results and analysis rather than manual labor. [6]

In 2011, ASI launched a proprietary software platform named GenASIs. The software automates the diagnostic manual process. Physicians, medical scientists and laboratory technicians integrate digital technology to manage the visualization of the slide and compute the analysis. Through algorithms, tissue suspension cell and chromosomes are analyzed for aberrations, cell classification, tumor proportion score etc. ASI's high throughput tray loader, introduced the same year, was manufactured to automate the sample and scanning process. [7] [6]

In 2017, ASI introduced PathFusion and HiPath Pro- the company's full pathology imaging suite for H&E, IHC, and FISH visualization and analysis software including tissue matching and whole slide imaging. [7] [6]

FDA Clearances

ASI has a wide FDA cleared portfolio. Its products and Quality System (QS) are compliant with IVD medical Device Standards and Regulations.

Patents

ASI patents cover methods and instrumentation for general fields in the life sciences. Some of the claims are specific to a special type of hardware. Others have a more general scope and refer to the application rather than the instrument. Some of the original patents are related to spectral imaging systems based on interferometry and other spectral imaging instrumentation. [9] [10] [11]

Functionalities

The functionalities that Applied Spectral Imaging provides laboratories and hospitals include automated slide scanning, applications interface, whole slide imaging, scoring and analysis, sharing capabilities for team review and final sign off, database management, secure archiving of reports, connectivity to the LIS and standardized testing.

Clinical applications

ASI's clinical applications for laboratories include the scoring of chromosome analysis and karyotyping, fluorescent karyotyping, spectral karyotyping, karyotyping of multiple species, scanning and detection of metaphases and interphases, FISH review and analysis, matching of tissue FISH with H&E/ IHC, Brightfield whole slide imaging, IHC quantitative scoring, Cytokinesis-blocked micronucleus, region of interest annotating and measuring, tissue matching and FISH imaging, analysis and documentation of membrane IHC stain, analysis and documentation of nuclear IHC stain, chromosome comparison modules, Whole Slide Image viewing, enhancement and documentation, data case management and network connectivity of multiple systems in a network.

Products

Related Research Articles

<span class="mw-page-title-main">Optical microscope</span> Microscope that uses visible light

The optical microscope, also referred to as a light microscope, is a type of microscope that commonly uses visible light and a system of lenses to generate magnified images of small objects. Optical microscopes are the oldest design of microscope and were possibly invented in their present compound form in the 17th century. Basic optical microscopes can be very simple, although many complex designs aim to improve resolution and sample contrast.

<span class="mw-page-title-main">Karyotype</span> Photographic display of total chromosome complement in a cell

A karyotype is the general appearance of the complete set of chromosomes in the cells of a species or in an individual organism, mainly including their sizes, numbers, and shapes. Karyotyping is the process by which a karyotype is discerned by determining the chromosome complement of an individual, including the number of chromosomes and any abnormalities.

<span class="mw-page-title-main">Cytogenetics</span> Branch of genetics

Cytogenetics is essentially a branch of genetics, but is also a part of cell biology/cytology, that is concerned with how the chromosomes relate to cell behaviour, particularly to their behaviour during mitosis and meiosis. Techniques used include karyotyping, analysis of G-banded chromosomes, other cytogenetic banding techniques, as well as molecular cytogenetics such as fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH).

Comparative genomic hybridization(CGH) is a molecular cytogenetic method for analysing copy number variations (CNVs) relative to ploidy level in the DNA of a test sample compared to a reference sample, without the need for culturing cells. The aim of this technique is to quickly and efficiently compare two genomic DNA samples arising from two sources, which are most often closely related, because it is suspected that they contain differences in terms of either gains or losses of either whole chromosomes or subchromosomal regions (a portion of a whole chromosome). This technique was originally developed for the evaluation of the differences between the chromosomal complements of solid tumor and normal tissue, and has an improved resolution of 5–10 megabases compared to the more traditional cytogenetic analysis techniques of giemsa banding and fluorescence in situ hybridization (FISH) which are limited by the resolution of the microscope utilized.

<span class="mw-page-title-main">Immunohistochemistry</span> Common application of immunostaining

Immunohistochemistry (IHC) is the most common application of immunostaining. It involves the process of selectively identifying antigens (proteins) in cells of a tissue section by exploiting the principle of antibodies binding specifically to antigens in biological tissues. IHC takes its name from the roots "immuno", in reference to antibodies used in the procedure, and "histo", meaning tissue. Albert Coons conceptualized and first implemented the procedure in 1941.

Fluorescence <i>in situ</i> hybridization Genetic testing technique

Fluorescence in situ hybridization (FISH) is a molecular cytogenetic technique that uses fluorescent probes that bind to only particular parts of a nucleic acid sequence with a high degree of sequence complementarity. It was developed by biomedical researchers in the early 1980s to detect and localize the presence or absence of specific DNA sequences on chromosomes. Fluorescence microscopy can be used to find out where the fluorescent probe is bound to the chromosomes. FISH is often used for finding specific features in DNA for use in genetic counseling, medicine, and species identification. FISH can also be used to detect and localize specific RNA targets in cells, circulating tumor cells, and tissue samples. In this context, it can help define the spatial-temporal patterns of gene expression within cells and tissues.

<span class="mw-page-title-main">Multispectral imaging</span> Capturing image data across multiple electromagnetic spectrum ranges

Multispectral imaging captures image data within specific wavelength ranges across the electromagnetic spectrum. The wavelengths may be separated by filters or detected with the use of instruments that are sensitive to particular wavelengths, including light from frequencies beyond the visible light range, i.e. infrared and ultra-violet. It can allow extraction of additional information the human eye fails to capture with its visible receptors for red, green and blue. It was originally developed for military target identification and reconnaissance. Early space-based imaging platforms incorporated multispectral imaging technology to map details of the Earth related to coastal boundaries, vegetation, and landforms. Multispectral imaging has also found use in document and painting analysis.

<i>In situ</i> hybridization

In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand to localize a specific DNA or RNA sequence in a portion or section of tissue or if the tissue is small enough, in the entire tissue, in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually localizes proteins in tissue sections.

<span class="mw-page-title-main">Hyperspectral imaging</span> Multi-wavelength imaging method

Hyperspectral imaging collects and processes information from across the electromagnetic spectrum. The goal of hyperspectral imaging is to obtain the spectrum for each pixel in the image of a scene, with the purpose of finding objects, identifying materials, or detecting processes. There are three general types of spectral imagers. There are push broom scanners and the related whisk broom scanners, which read images over time, band sequential scanners, which acquire images of an area at different wavelengths, and snapshot hyperspectral imagers, which uses a staring array to generate an image in an instant.

<span class="mw-page-title-main">Molecular cytogenetics</span>

Molecular cytogenetics combines two disciplines, molecular biology and cytogenetics, and involves the analysis of chromosome structure to help distinguish normal and cancer-causing cells. Human cytogenetics began in 1956 when it was discovered that normal human cells contain 46 chromosomes. However, the first microscopic observations of chromosomes were reported by Arnold, Flemming, and Hansemann in the late 1800s. Their work was ignored for decades until the actual chromosome number in humans was discovered as 46. In 1879, Arnold examined sarcoma and carcinoma cells having very large nuclei. Today, the study of molecular cytogenetics can be useful in diagnosing and treating various malignancies such as hematological malignancies, brain tumors, and other precursors of cancer. The field is overall focused on studying the evolution of chromosomes, more specifically the number, structure, function, and origin of chromosome abnormalities. It includes a series of techniques referred to as fluorescence in situ hybridization, or FISH, in which DNA probes are labeled with different colored fluorescent tags to visualize one or more specific regions of the genome. Introduced in the 1980s, FISH uses probes with complementary base sequences to locate the presence or absence of the specific DNA regions. FISH can either be performed as a direct approach to metaphase chromosomes or interphase nuclei. Alternatively, an indirect approach can be taken in which the entire genome can be assessed for copy number changes using virtual karyotyping. Virtual karyotypes are generated from arrays made of thousands to millions of probes, and computational tools are used to recreate the genome in silico.

Chemical imaging is the analytical capability to create a visual image of components distribution from simultaneous measurement of spectra and spatial, time information. Hyperspectral imaging measures contiguous spectral bands, as opposed to multispectral imaging which measures spaced spectral bands.

<span class="mw-page-title-main">Airborne Real-time Cueing Hyperspectral Enhanced Reconnaissance</span> Aerial imaging system

Airborne Real-time Cueing Hyperspectral Enhanced Reconnaissance, also known by the acronym ARCHER, is an aerial imaging system that produces ground images far more detailed than plain sight or ordinary aerial photography can. It is the most sophisticated unclassified hyperspectral imaging system available, according to U.S. Government officials. ARCHER can automatically scan detailed imaging for a given signature of the object being sought, for abnormalities in the surrounding area, or for changes from previous recorded spectral signatures.

Electro-optical MASINT is a subdiscipline of Measurement and Signature Intelligence, (MASINT) and refers to intelligence gathering activities which bring together disparate elements that do not fit within the definitions of Signals Intelligence (SIGINT), Imagery Intelligence (IMINT), or Human Intelligence (HUMINT).

<span class="mw-page-title-main">Digital pathology</span>

Digital pathology is a sub-field of pathology that focuses on data management based on information generated from digitized specimen slides. Through the use of computer-based technology, digital pathology utilizes virtual microscopy. Glass slides are converted into digital slides that can be viewed, managed, shared and analyzed on a computer monitor. With the practice of Whole-Slide Imaging (WSI), which is another name for virtual microscopy, the field of digital pathology is growing and has applications in diagnostic medicine, with the goal of achieving efficient and cheaper diagnoses, prognosis, and prediction of diseases due to the success in machine learning and artificial intelligence in healthcare.

<span class="mw-page-title-main">Automated tissue image analysis</span>

Automated tissue image analysis or histopathology image analysis (HIMA) is a process by which computer-controlled automatic test equipment is used to evaluate tissue samples, using computations to derive quantitative measurements from an image to avoid subjective errors.

Virtual karyotype is the digital information reflecting a karyotype, resulting from the analysis of short sequences of DNA from specific loci all over the genome, which are isolated and enumerated. It detects genomic copy number variations at a higher resolution for level than conventional karyotyping or chromosome-based comparative genomic hybridization (CGH). The main methods used for creating virtual karyotypes are array-comparative genomic hybridization and SNP arrays.

Chromogenic in situ hybridization (CISH) is a cytogenetic technique that combines the chromogenic signal detection method of immunohistochemistry (IHC) techniques with in situ hybridization. It was developed around the year 2000 as an alternative to fluorescence in situ hybridization (FISH) for detection of HER-2/neu oncogene amplification. CISH is similar to FISH in that they are both in situ hybridization techniques used to detect the presence or absence of specific regions of DNA. However, CISH is much more practical in diagnostic laboratories because it uses bright-field microscopes rather than the more expensive and complicated fluorescence microscopes used in FISH.

CytoViva, Inc. is a scientific imaging and instrumentation company that develops and markets optical microscopy and hyperspectral imaging technology for nanomaterials, pathogen and general biology applications.

Photon etc. is a Canadian manufacturer of infrared cameras, widely tunable optical filters, hyperspectral imaging and spectroscopic scientific instruments for academic and industrial applications. Its main technology is based on volume Bragg gratings, which are used as filters either for swept lasers or for global imaging.

Spatio-spectral scanning is one of four techniques for hyperspectral imaging, the other three being spatial scanning, spectral scanning and non-scanning, or snapshot hyperspectral imaging.

References

  1. "Company Overview of Applied Spectral Imaging, Inc". Bloomberg.com. 4 Oct 2017. Retrieved 31 December 2018.
  2. "Hyperspectral Imaging System Market Research on Technology Advancements 2019". Master Journals. 31 December 2018. Archived from the original on 8 January 2019. Retrieved 1 January 2019.
  3. "Airborne Hyperspectral Imaging Systems Market to Witness Huge Growth by 2023 - Leading Key Players: Telops, Norsk Elektro Optikk, Specim, Spectral Imaging". Tribune Updates. 20 December 2018. Archived from the original on 8 January 2019. Retrieved 1 January 2019.
  4. Symond, Vinay (25 December 2018). "Hyperspectral Imaging System Market with top 20 Countries data : Changing Dynamics Of Competition With Forecast To 2023". DigiTribune. Archived from the original on 8 January 2019. Retrieved 1 January 2019.
  5. "Hyperspectral Imaging Camera Market to Gain a Stronghold by 2028". Journal of Industry. 18 December 2018. Retrieved 1 January 2019.[ permanent dead link ]
  6. 1 2 3 4 5 "Company History: Applied Spectral Imaging (ASI)" (PDF). Applied Spectral Imaging (ASI). Retrieved 1 January 2019.
  7. 1 2 "Applied Spectral Imaging (ASI) - News & Events" . Retrieved 1 January 2019.
  8. "Applied Spectral Imaging Receives FDA Clearance for GenASIs HiPath IHC Family". MPO Magazine. 7 May 2015. Retrieved 31 December 2018.
  9. US 5784162
  10. US 6556853
  11. US 5991028
  12. "Applied Spectral Imaging (ASI) - Official website" . Retrieved 1 January 2019.